Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tuomas A Tolvanen

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Cell Science|November 8, 2015
Lack of CD2AP disrupts Glut4 trafficking and attenuates glucose uptake in podocytesTuomas A Tolvanen, Surjya Narayan Dash, Zydrune Polianskyte-Prause, et al.
Scientific Reports|September 8, 2017
Inhibition of SHIP2 in CD2AP-deficient podocytes ameliorates reactive oxygen species generation but aggravates apoptosisPauliina Saurus, Tuomas A Tolvanen, Sonja Lindfors, et al.
Scientific Reports|August 5, 2022
Functional human cell-based vascularised cardiac tissue model for biomedical research and testingMaria Koivisto, Tuomas A Tolvanen, Tarja Toimela, et al.
ACS Omega|February 4, 2020
Novel Sulfonanilide Inhibitors of SHIP2 Enhance Glucose Uptake into Cultured MyotubesMika E A Berg, Jette-Britt Naams, Laura C Hautala, et al.
International Journal of Biological Sciences|March 28, 2022
Ebselen enhances insulin sensitivity and decreases oxidative stress by inhibiting SHIP2 and protects from inflammation in diabetic miceZydrune Polianskyte-Prause, Tuomas A Tolvanen, Sonja Lindfors, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 28, 2017
PACSIN2 accelerates nephrin trafficking and is up-regulated in diabetic kidney diseaseVincent Dumont, Tuomas A Tolvanen, Sara Kuusela, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 16, 2018
Metformin increases glucose uptake and acts renoprotectively by reducing SHIP2 activityZydrune Polianskyte-Prause, Tuomas A Tolvanen, Sonja Lindfors, et al.
European Journal of Medicinal Chemistry|August 29, 2025
Development of pyrazolo[1,5-a]pyrimidine based macrocyclic kinase inhibitors targeting AAK1Theresa E Mensing, Christian G Kurz, Jennifer A Amrhein, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Cell Science|November 8, 2015
Lack of CD2AP disrupts Glut4 trafficking and attenuates glucose uptake in podocytesTuomas A Tolvanen, Surjya Narayan Dash, Zydrune Polianskyte-Prause, et al.
Scientific Reports|September 8, 2017
Inhibition of SHIP2 in CD2AP-deficient podocytes ameliorates reactive oxygen species generation but aggravates apoptosisPauliina Saurus, Tuomas A Tolvanen, Sonja Lindfors, et al.
Scientific Reports|August 5, 2022
Functional human cell-based vascularised cardiac tissue model for biomedical research and testingMaria Koivisto, Tuomas A Tolvanen, Tarja Toimela, et al.
ACS Omega|February 4, 2020
Novel Sulfonanilide Inhibitors of SHIP2 Enhance Glucose Uptake into Cultured MyotubesMika E A Berg, Jette-Britt Naams, Laura C Hautala, et al.
International Journal of Biological Sciences|March 28, 2022
Ebselen enhances insulin sensitivity and decreases oxidative stress by inhibiting SHIP2 and protects from inflammation in diabetic miceZydrune Polianskyte-Prause, Tuomas A Tolvanen, Sonja Lindfors, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 28, 2017
PACSIN2 accelerates nephrin trafficking and is up-regulated in diabetic kidney diseaseVincent Dumont, Tuomas A Tolvanen, Sara Kuusela, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 16, 2018
Metformin increases glucose uptake and acts renoprotectively by reducing SHIP2 activityZydrune Polianskyte-Prause, Tuomas A Tolvanen, Sonja Lindfors, et al.
European Journal of Medicinal Chemistry|August 29, 2025
Development of pyrazolo[1,5-a]pyrimidine based macrocyclic kinase inhibitors targeting AAK1Theresa E Mensing, Christian G Kurz, Jennifer A Amrhein, et al.
Pageof 1